Novotech

News

Moderna Reports Positive COVID-19 Vaccine Results in Adolescents

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Phase 2/3 study of its COVID-19 vaccine (mRNA-1273) in adolescents has met its primary immunogenicity endpoint, successfully bridging immune responses to the adult vaccination....

CanSino Biologics Gets OGYEI GMP Certificate for COVID Vax

CanSino Biologics Recombinant Novel Coronavirus Vaccine, (Adenovirus Type 5 Vector, trade name Convidecia), has been granted a Good Manufacturing Practice certificate by the Hungarian National Institute of Pharmacy and Nutrition (OGYร‰I). The certification was issued on May 21, 2021...

ANVISA Sorrento Phase 2 Pivotal Clinical Trial of COVI-MSC in Hospitalized COVID-19 Patients With Acute Respiratory Distress Syndrome

Sorrento Therapeutics, Inc. announced receipt of clearance from the Brazilian regulatory agency (ANVISA) to proceed with a Phase 2 Pivotal clinical trial of COVI-MSCโ„ข, an injectable infusion of mesenchymal stem cells, for the treatment of hospitalized COVID-19 patients suffering...

Scitara Raises $5 Million to Accelerate Digital Transformation of Scientific Laboratories

Scitara Corporation, a global provider of laboratory-specific, cloud-based software solutions for the biopharmaceutical and industrial markets, announced the closing of $5 million in a Series A round. The investment was led by Northpond Ventures, with participation from existing investor...

Potential Impact of Takeda’s Dengue Vaccine Candidate Reinforced by Long-Term Safety and Efficacy Results

Takeda Pharmaceutical Company Limited ("Takeda") announced that its dengue vaccine candidate (TAK-003) demonstrated continued protection against dengue illness and hospitalization, regardless of an individual's previous dengue exposure, with no important safety risks identified through three years after vaccination in...

Sharp purchases new land as part of $17 million capacity expansion

Sharp, part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has purchased new land as part of a $17 million investment into its Conshohocken, PA site. The new 4-acre plot is directly adjacent to...

Agilex Biolabs Toxicology Tapped for SARS-CoV-2 Vaccine Research

Agilex Biolabs, Australiaโ€™s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, said biotechs with first-in-human studies can leverage significant quality, speed and cost advantages working with their company TetraQ toxicology for pre-clinical research in Australia. TetraQ is...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป